OCT Angiography in Wet AMD

Neovascular (Wet) Age-related Macular Degeneration (AMD) Clinical Trial

Official title: Optical Coherence Tomography Angiography in Neovascular Age-related Macular Degeneration

Status Recruiting

Clinical Trial Summary

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to:

1. diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD)

2. evaluate patients undergoing treatment for wet AMD

3. determine if reduced flow to the choroid is a risk factor for developing wet AMD.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Macular Degeneration
• Neovascular (Wet) Age-related Macular Degeneration (AMD)

• NCT number: NCT02253030
• Study type: Observational
• Source: Oregon Health and Science University
• Contact: George Pacheco, COA
• Phone: 503-494-7398
• Email: pachecge@ohsu.edu
• Status: Recruiting
• Start date: September 2014
• Completion date: December 2026